TLR4 and cardiac hypertrophy: A recent study demonstrated that mice lacking MD2 (one of TLR4 co-receptor) were resistant to Ang II-induced cardiac hypertrophy in conjunction with reduced phosphorylation of ERK and subsequent cardiac inflammation, suggesting that TLR4/MD2/ERK signaling exerts pro-hypertrophic effects in the heart (31).